Using ctDNA to guide immunotherapy for urothelial cancer

被引：3
|
作者：
Fenner, Annette
机构：
[1] Nature Reviews Urology,
来源：
NATURE REVIEWS UROLOGY | 2021年 / 18卷 / 08期
关键词：
D O I：
10.1038/s41585-021-00503-y
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：443 / 443
页数：1
相关论文
共 50 条
  • [41] Systemic therapy issues: Immunotherapy in nonmetastatic urothelial cancer
    Nadal, Rosa
    Apolo, Andrea B.
    Girardi, Daniel M.
    Hahn, Noah M.
    Bellmunt, Joaquim
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (01) : 27 - 34
  • [42] Immunotherapy in Urothelial Cancer: Recent Results and Future Perspectives
    Matthew S. Farina
    Kevin T. Lundgren
    Joaquim Bellmunt
    Drugs, 2017, 77 : 1077 - 1089
  • [43] Immunotherapy in Urothelial Cancer: Recent Results and Future Perspectives
    Farina, Matthew S.
    Lundgren, Kevin T.
    Bellmunt, Joaquim
    DRUGS, 2017, 77 (10) : 1077 - 1089
  • [44] CtDNA as a predictor of outcome in patients treated with neoadjuvant atezolizumab in muscle invasive urothelial cancer
    Powles, T.
    Szabados, B.
    Castellano, D.
    Rodriguez-Vida, A.
    Valderrama, B.
    Crabb, S.
    Van der Heijden, M.
    Pous, A. F.
    Prendergast, A.
    Gravis, G.
    Herranz, U. A.
    Sharma, S.
    Ravauld, A.
    Sethi, H.
    Zimmerman, B.
    Aleshin, A.
    Kockx, M.
    Banchereau, R.
    Mariathasan, S.
    Assaf, Z. J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) : 911 - 911
  • [45] IMMUNOTHERAPY OF EXPERIMENTAL CANCER AS A GUIDE TO TREATMENT OF HUMAN CANCER
    RAPP, HJ
    KLEINSCHUSTER, SJ
    LUEKER, DC
    KAINER, RA
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1976, 276 (SEP3) : 550 - 556
  • [46] Predicting survival in urothelial cancer patients after immunotherapy using real-world data
    Elumalai, T.
    Aversa, C.
    Buijtenhuijs, B.
    Conroy, R.
    Croxford, W.
    Das, A.
    Doss, G.
    Enting, D.
    Kitetere, E.
    Sanderson, B.
    Vasudev, N.
    Mistry, H.
    Choudhury, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S590 - S590
  • [47] Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
    Beatty, Gregory L.
    Gladney, Whitney L.
    CLINICAL CANCER RESEARCH, 2015, 21 (04) : 687 - 692
  • [48] Immunotherapy in non-metastatic urothelial cancer: back to the "future'
    Darling, H. S.
    Bellmunt, Joaquim
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (07) : 685 - 695
  • [49] Immunotherapy for urothelial cancer: from BCG to checkpoint inhibitors and beyond
    Wu, Yin
    Enting, Deborah
    Rudman, Sarah
    Chowdhury, Simon
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (05) : 509 - 523
  • [50] Role of urothelial cells in BCG immunotherapy for superficial bladder cancer
    R F M Bevers
    K-H Kurth
    D H J Schamhart
    British Journal of Cancer, 2004, 91 : 607 - 612
12345